Synonyms: ABT-450 | ABT450 | veruprevir (deprecated INN) | Viekirax® (ombitasvir + paritaprevir + ritonavir; EU)
paritaprevir is an approved drug (FDA (2015), EMA (2020))
Compound class:
Synthetic organic
Comment: Paritaprevir is an orally bioavailable, direct-acting inhibitor of the hepatitis C virus (HCV) non-structural protein 3 and 4A (NS3/NS4A) protease complex [1]. It blocks NS3/NS4A protease-mediated polyprotein maturation, thus disrupting viral replication.
|
|
Classification | |
Compound class | Synthetic organic |
Approved drug? | Yes (FDA (2015), EMA (2020)) |
Withdrawn drug? | Yes |
WHO Essential Medicine | WHO Essential Medicines List (EML) (23rd List, 2023). Access PDF version. Click to view more information about the WHO Model Lists of Essential Medicines. |
International Nonproprietary Names | |
INN number | INN |
9739 | paritaprevir |
Synonyms |
ABT-450 | ABT450 | veruprevir (deprecated INN) | Viekirax® (ombitasvir + paritaprevir + ritonavir; EU) |
Database Links | |
CAS Registry No. | 1216941-48-8 (source: WHO INN record) |
ChEMBL Ligand | CHEMBL3391662 |
DrugBank Ligand | DB09297 |
DrugCentral Ligand | 4913 |
GtoPdb PubChem SID | 434321708 |
PubChem CID | 45110509 |
Search Google for chemical match using the InChIKey | UAUIUKWPKRJZJV-QPLHLKROSA-N |
Search Google for chemicals with the same backbone | UAUIUKWPKRJZJV |
Search PubMed clinical trials | paritaprevir |
Search PubMed titles | paritaprevir |
Search PubMed titles/abstracts | paritaprevir |
UniChem Compound Search for chemical match using the InChIKey | UAUIUKWPKRJZJV-QPLHLKROSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | UAUIUKWPKRJZJV-QPLHLKROSA-N |